Second International Urology Cancer Summit
27.09.24 – Portsmouth, UK
Time zone is BST (British Summer Time)
Faculty 2024
Giuseppe Banna
UK
Ravindran Kanesvaran
Singapore
Neeraj Agarwal
USA
Monty Pal
USA
Alison Tree
UK
Yüksel Ürün
TURKEY
Simon Crabb
UK
Pasquale Rescigno
UK
Christian Rolfo
USA
Ananya Choudhury
UK
Param Mariappan
UK
Akash Maniam
UK
Laura Marandino
UK
Naveen Vasudev
UK
Patrizia Giannatempo
ITALY
Programme 2024
09:00
Welcome by Chairs
Giuseppe Luigi Banna (UK) & Ravindran Kanesvaran (Singapore)
Urothelial Cancer
09:05 – 09:25
The role of immunotherapy in the evolving treatment landscape of UC
Simon Crabb, Southampton, UK
09:25- 09:45
Shall we treat mUTUC in a different way
Patrizia Giannatempo, Milan, Italy
09:45 – 10:05
Contemporary options in non-metastatic bladder cancer
Param Mariappan, Edinburgh, UK
10:05 – 10:25
Who is suitable for bladder sparing treatment in 2024?
Ananya Choudhury, Manchester, UK
Diagnostics and Biomarkers
10:25 – 10:45
Staging by imaging: Where we stand in prostate cancer
Akash Maniam, Portsmouth, UK
10:45 – 11:05
Liquid vs tumour biopsy in urological tumours
Christian Rolfo, New York, US
11:05 – 11:20
Coffee Break – (ePoster Session)
Prostate Cancer
11:20 – 11:40
Treatment escalation and de-escalation in mHSPC
Pasquale Rescigno, Newcastle, UK
11:40 – 12:00
How first- and second-line treatment of mCRPC is evolving
Neeraj Agarwal, Salt Lake City, US
12:00 – 12:20
Patient-friendly fractionation for localised disease
Alison Tree, London, UK
12:20 – 15:00
Industry Symposia – View List
(including lunch break)
13:20 – 14:15
Lunch – (ePoster Session)
15:00 – 15:20
Poster Award
Renal
15:20 – 15:40
Intensification and de-intensification in the treatment of mRCC
Monty Pal, Los Angeles, US
15:40 – 16:00
Updating treatment sequencing for mRCC
Naveen Vasudev, Leeds, UK
Clinical Case Quiz
16:00 – 16:20
Clinical Case Quiz
Yüksel Ürün, Ankara, Turkey
16:20 – 16:35
Coffee break (ePoster Session)
Real-world
16:35 – 16:55
Inequity as a barrier to access
Ravindran Kanesvaran, Singapore
16:55 – 17:15
The relevance of QoL outcomes in clinical trials and the real world
Laura Marandino, London, UK
17:15
Closure remarks
The organisers of IUCS 2024 gratefully acknowledge the support of the following companies:
